US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist
  • 1.140
  • +0.010+0.88%
Close Nov 1 16:00 ET
  • 1.140
  • 0.0000.00%
Post 20:01 ET
80.91MMarket Cap-2780P/E (TTM)

Ovid Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.77%-14.26M
-37.77%-16.69M
17.10%-45.78M
-29.82%-11.91M
20.71%-10.05M
11.90%-11.71M
39.71%-12.11M
-146.56%-55.23M
23.53%-9.18M
-16.60%-12.68M
Net income from continuing operations
168.66%8.52M
12.44%-11.69M
3.38%-52.34M
-33.18%-15.32M
5.98%-11.25M
14.94%-12.41M
17.08%-13.36M
-144.10%-54.17M
55.75%-11.5M
-5.13%-11.97M
Depreciation and amortization
-1.72%-118K
1.01%402K
15.56%1.6M
-8.76%401.39K
119.85%913.18K
-125.64%-116K
439.24%398K
482.76%1.38M
672.51%439.95K
696.05%415.37K
Other non cash items
-7,756.74%-29.56M
-177.78%-1.23M
-121.86%-2.71M
-801.56%-932.67K
-444.68%-1.72M
585.78%386K
48.55%-441K
-116.71%-1.22M
---103.45K
---315.51K
Change In working capital
507.79%4.19M
-544.44%-1.74M
128.98%2.39M
5,623.11%3.65M
101.23%29.11K
30.84%-1.03M
93.74%-270K
51.05%-8.23M
-101.24%-66.15K
-237.31%-2.37M
-Change in prepaid assets
76.68%-1M
215.93%853K
-1,367.29%-1.39M
314.65%864.85K
1,444.02%1.79M
-810.19%-4.31M
4.60%270K
-78.89%109.29K
-64.96%208.57K
-76.70%115.68K
-Change in payables and accrued expense
58.34%5.19M
-380.19%-2.59M
145.21%3.77M
1,115.07%2.79M
29.24%-1.76M
424.02%3.28M
88.19%-540K
-63.83%-8.34M
-105.80%-274.72K
-107.22%-2.48M
Cash from discontinued investing activities
Operating cash flow
-21.78%-14.26M
-37.76%-16.69M
17.10%-45.78M
-29.82%-11.91M
20.71%-10.05M
11.91%-11.71M
39.70%-12.11M
-146.56%-55.23M
23.53%-9.18M
-16.60%-12.68M
Investing cash flow
Cash flow from continuing investing activities
-36.10%12.82M
-33.21%20.19M
97.06%-2.58M
-1,063.59%-48.52M
-122.38%-4.36M
124.87%20.07M
2,908.86%30.23M
-4,725.04%-87.88M
-2,474.44%-4.17M
-2,961.38%-1.96M
Net PPE purchase and sale
-385.71%-34K
-35.71%-19K
96.71%-40.31K
88.57%-13.71K
69.88%-5.6K
99.33%-7K
69.52%-14K
-565.39%-1.22M
25.94%-119.94K
15.65%-18.6K
Net intangibles purchase and sale
----
----
50.03%-97.15K
-78.07%12.49K
--363
----
----
-3,499.94%-194.4K
--56.94K
--0
Net business purchase and sale
----
----
-300.00%-10M
--0
--0
----
----
-53.19%-2.5M
--0
-5,097.61%-2.5M
Net investment purchase and sale
-57.02%12.97M
-33.18%20.21M
109.11%7.56M
-1,081.42%-48.51M
-879.94%-4.35M
138.01%30.18M
--30.24M
---82.96M
---4.11M
--558.28K
Net other investing changes
----
----
----
----
----
----
100.10%1K
---1M
--0
--0
Cash from discontinued investing activities
Investing cash flow
-36.10%12.82M
-33.22%20.19M
97.06%-2.58M
-1,063.59%-48.52M
-122.38%-4.36M
124.87%20.07M
2,908.96%30.23M
-4,725.04%-87.88M
-2,474.44%-4.17M
-2,961.38%-1.96M
Financing cash flow
Cash flow from continuing financing activities
68.72%356K
240.30%228K
16,802.21%30.54M
68,985.51%30.03M
174.18%223.81K
92.61%211K
102.55%67K
-80.02%180.66K
-139.93%-43.6K
-85.13%81.63K
Proceeds from stock option exercised by employees
68.72%356K
240.30%228K
196.25%535.2K
176.59%33.39K
174.18%223.81K
92.61%211K
102.55%67K
-80.48%180.66K
-139.93%-43.6K
-85.13%81.63K
Net other financing activities
----
----
--30M
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
68.72%356K
240.30%228K
16,802.21%30.54M
68,985.51%30.03M
174.18%223.81K
92.61%211K
102.55%67K
-80.02%180.66K
-139.93%-43.6K
-85.13%81.63K
Net cash flow
Beginning cash position
-49.67%32.7M
-38.09%28.97M
-75.33%46.8M
-1.36%59.37M
-1.59%73.55M
-61.46%64.98M
-75.33%46.8M
163.39%189.73M
-70.17%60.19M
-64.77%74.74M
Current changes in cash
-112.59%-1.08M
-79.48%3.73M
87.53%-17.83M
-127.02%-30.4M
2.53%-14.19M
109.13%8.57M
186.06%18.18M
-221.44%-142.93M
-11.10%-13.39M
-40.13%-14.56M
End cash Position
-57.00%31.63M
-49.67%32.7M
-38.09%28.97M
-38.09%28.97M
-1.36%59.37M
-1.59%73.55M
-61.46%64.98M
-75.33%46.8M
-75.33%46.8M
-70.17%60.19M
Free cash flow
-21.84%-14.41M
-37.76%-16.71M
18.94%-45.92M
-28.95%-11.91M
20.79%-10.06M
18.74%-11.82M
39.86%-12.13M
-147.83%-56.65M
24.03%-9.24M
-16.60%-12.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.77%-14.26M-37.77%-16.69M17.10%-45.78M-29.82%-11.91M20.71%-10.05M11.90%-11.71M39.71%-12.11M-146.56%-55.23M23.53%-9.18M-16.60%-12.68M
Net income from continuing operations 168.66%8.52M12.44%-11.69M3.38%-52.34M-33.18%-15.32M5.98%-11.25M14.94%-12.41M17.08%-13.36M-144.10%-54.17M55.75%-11.5M-5.13%-11.97M
Depreciation and amortization -1.72%-118K1.01%402K15.56%1.6M-8.76%401.39K119.85%913.18K-125.64%-116K439.24%398K482.76%1.38M672.51%439.95K696.05%415.37K
Other non cash items -7,756.74%-29.56M-177.78%-1.23M-121.86%-2.71M-801.56%-932.67K-444.68%-1.72M585.78%386K48.55%-441K-116.71%-1.22M---103.45K---315.51K
Change In working capital 507.79%4.19M-544.44%-1.74M128.98%2.39M5,623.11%3.65M101.23%29.11K30.84%-1.03M93.74%-270K51.05%-8.23M-101.24%-66.15K-237.31%-2.37M
-Change in prepaid assets 76.68%-1M215.93%853K-1,367.29%-1.39M314.65%864.85K1,444.02%1.79M-810.19%-4.31M4.60%270K-78.89%109.29K-64.96%208.57K-76.70%115.68K
-Change in payables and accrued expense 58.34%5.19M-380.19%-2.59M145.21%3.77M1,115.07%2.79M29.24%-1.76M424.02%3.28M88.19%-540K-63.83%-8.34M-105.80%-274.72K-107.22%-2.48M
Cash from discontinued investing activities
Operating cash flow -21.78%-14.26M-37.76%-16.69M17.10%-45.78M-29.82%-11.91M20.71%-10.05M11.91%-11.71M39.70%-12.11M-146.56%-55.23M23.53%-9.18M-16.60%-12.68M
Investing cash flow
Cash flow from continuing investing activities -36.10%12.82M-33.21%20.19M97.06%-2.58M-1,063.59%-48.52M-122.38%-4.36M124.87%20.07M2,908.86%30.23M-4,725.04%-87.88M-2,474.44%-4.17M-2,961.38%-1.96M
Net PPE purchase and sale -385.71%-34K-35.71%-19K96.71%-40.31K88.57%-13.71K69.88%-5.6K99.33%-7K69.52%-14K-565.39%-1.22M25.94%-119.94K15.65%-18.6K
Net intangibles purchase and sale --------50.03%-97.15K-78.07%12.49K--363---------3,499.94%-194.4K--56.94K--0
Net business purchase and sale ---------300.00%-10M--0--0---------53.19%-2.5M--0-5,097.61%-2.5M
Net investment purchase and sale -57.02%12.97M-33.18%20.21M109.11%7.56M-1,081.42%-48.51M-879.94%-4.35M138.01%30.18M--30.24M---82.96M---4.11M--558.28K
Net other investing changes ------------------------100.10%1K---1M--0--0
Cash from discontinued investing activities
Investing cash flow -36.10%12.82M-33.22%20.19M97.06%-2.58M-1,063.59%-48.52M-122.38%-4.36M124.87%20.07M2,908.96%30.23M-4,725.04%-87.88M-2,474.44%-4.17M-2,961.38%-1.96M
Financing cash flow
Cash flow from continuing financing activities 68.72%356K240.30%228K16,802.21%30.54M68,985.51%30.03M174.18%223.81K92.61%211K102.55%67K-80.02%180.66K-139.93%-43.6K-85.13%81.63K
Proceeds from stock option exercised by employees 68.72%356K240.30%228K196.25%535.2K176.59%33.39K174.18%223.81K92.61%211K102.55%67K-80.48%180.66K-139.93%-43.6K-85.13%81.63K
Net other financing activities ----------30M----------------------------
Cash from discontinued financing activities
Financing cash flow 68.72%356K240.30%228K16,802.21%30.54M68,985.51%30.03M174.18%223.81K92.61%211K102.55%67K-80.02%180.66K-139.93%-43.6K-85.13%81.63K
Net cash flow
Beginning cash position -49.67%32.7M-38.09%28.97M-75.33%46.8M-1.36%59.37M-1.59%73.55M-61.46%64.98M-75.33%46.8M163.39%189.73M-70.17%60.19M-64.77%74.74M
Current changes in cash -112.59%-1.08M-79.48%3.73M87.53%-17.83M-127.02%-30.4M2.53%-14.19M109.13%8.57M186.06%18.18M-221.44%-142.93M-11.10%-13.39M-40.13%-14.56M
End cash Position -57.00%31.63M-49.67%32.7M-38.09%28.97M-38.09%28.97M-1.36%59.37M-1.59%73.55M-61.46%64.98M-75.33%46.8M-75.33%46.8M-70.17%60.19M
Free cash flow -21.84%-14.41M-37.76%-16.71M18.94%-45.92M-28.95%-11.91M20.79%-10.06M18.74%-11.82M39.86%-12.13M-147.83%-56.65M24.03%-9.24M-16.60%-12.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data